A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Pancreatic Cancer|Colorectal Cancer|Non-small Cell Lung Cancer|Head and Neck Cancer|Cancer of Unknown Primary Site|Ovarian Cancer|Breast Cancer|Soft Tissue Sarcoma|Bladder Cancer|Oesophageal Cancer|Prostate Cancer|Biliary Tract Cancer
Interventions: DRUG: AVA6000
Sponsor: Avacta Life Sciences Ltd